Living with Lichen Planus can be frustrating because it is an inflammatory condition that affects the skin and mouth. Identifying exactly what is happening in the body during these flare-ups is a major challenge for doctors trying to provide the best care.
A large review of data looked at small particles in the body called extracellular vesicles. These tiny carriers carry proteins and genetic material, known as miRNA. The study found that certain markers, like miR-4484 and a combination of GJA1 and Cx43, showed good to strong ability to distinguish those with the condition from healthy people.
While these findings are promising for identifying the disease and understanding how it causes tissue injury, there is still work to do. The study notes that some sample sizes were small and methods varied across different tests. These markers are currently considered potential candidates rather than confirmed tools for everyday use.
Common questions
What are these new biomarkers?
The study looked at extracellular vesicles, which are tiny particles in the body. These carry specific markers like miR-4484 and a combination of GJA1 and Cx43. These markers showed good to strong ability to help distinguish people with Lichen Planus or Oral Lichen Planus from those without the condition.
How accurate are these tests for diagnosis?
The research showed that the combination of GJA1 and Cx43 had the strongest ability to differentiate cases, with a score of 0.892. Overall, the pooled results for these markers showed good discrimination in identifying the condition.
Are these tests ready to use in clinics?
Not yet. While these proteins and genetic markers are promising candidates for diagnosis and understanding how the disease causes injury, they are not yet confirmed as definitive biomarkers. The study noted some limitations like small sample sizes and different testing methods.